Auf dem Laufenden bleiben

Erhalten Sie eine woechentliche Zusammenfassung der neuesten psychedelischen Forschung, neuer Studien und Plattform-Updates direkt in Ihren Posteingang.

Kein Spam, nie. Jederzeit abbestellbar.

Wayne C Drevets

Janssen Research & Development, LLC, a Johnson & Johnson company, San Diego, California.

Studien (6)

Effect of Esketamine on Depressive Symptoms in Adolescents With Major Depressive Disorder at Imminent Suicide Risk: A Randomized Psychoactive-Controlled Study.

27. Dez. 2025RCTKo-Autor

Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study.

16. Juni 2023Open-LabelKo-Autor

Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II).

28. Jan. 2022RCTKo-Autor

Meaningful Change in Depression Symptoms Assessed with the Patient Health Questionnaire (PHQ-9) and Montgomery-Åsberg Depression Rating Scale (MADRS) Among Patients with Treatment Resistant Depression in Two, Randomized, Double-blind, Active-controlled Trials of Esketamine Nasal Spray Combined With a New Oral Antidepressant.

23. Apr. 2021RCTKo-Autor

14. Sept. 2020RCTKo-Autor

8. Juli 2019RCTKo-Autor

Übersicht

Publikationen: 6
Erstautor: 0
Ko-Autor: 6

Studientypen

RCT5

Open-Label1

Links

—

X LinkedIn Email